Magnesium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14513 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 93 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | severe nonproliferative diabetic retinopathy | KG + DL |
| 4 | bronchitis | KG + DL |
| 5 | diabetic retinopathy | KG + DL |
| 6 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 7 | dermatitis | KG + DL |
| 8 | hyperthyroidism | KG + DL |
| 9 | rheumatoid arthritis | KG + DL |
| 10 | dry eye syndrome | KG + DL |
| 11 | primary hereditary glaucoma | KG + DL |
| 12 | acrodermatitis chronica atrophicans | KG + DL |
| 13 | methemoglobinemia, alpha type | KG + DL |
| 14 | open-angle glaucoma | KG + DL |
| 15 | neonatal dermatomyositis | KG + DL |
| 16 | myositis fibrosa | KG + DL |
| 17 | idiopathic granulomatous myositis | KG + DL |
| 18 | tendinitis | KG + DL |
| 19 | methemoglobin reductase deficiency | KG + DL |
| 20 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 21 | amyopathic dermatomyositis | KG + DL |
| 22 | atrophoderma vermiculata | KG + DL |
| 23 | thrombotic disease | KG + DL |
| 24 | fibromyalgia | KG + DL |
| 25 | ulerythema ophryogenesis | KG + DL |
| 26 | hyperthyroxinemia | KG + DL |
| 27 | hydroa vacciniforme, familial | KG + DL |
| 28 | acne keloid | KG + DL |
| 29 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 30 | brachydactyly-syndactyly syndrome | KG + DL |
| 31 | excretory apparatus of the lacrimal system anomaly | KG + DL |
| 32 | anaphylaxis | KG + DL |
| 33 | ulcerative colitis (disease) | KG + DL |
| 34 | migraine with or without aura, susceptibility to | KG + DL |
| 35 | hyperplasia | KG + DL |
| 36 | skin disease | KG + DL |
| 37 | inclusion body myositis | KG + DL |
| 38 | disorder of lacrimal gland | KG + DL |
| 39 | nasolacrimal duct disease | KG + DL |
| 40 | biotin metabolic disease | KG + DL |
| 41 | anomaly of the secretory and excretory apparatus of the lacrimal system | KG + DL |
| 42 | secretory apparatus of the lacrimal system anomaly | KG + DL |
| 43 | lacrimal passage granuloma | KG + DL |
| 44 | eversion of lacrimal punctum | KG + DL |
| 45 | lacrimal atrophy | KG + DL |
| 46 | stenosis of lacrimal sac | KG + DL |
| 47 | erythema palmare hereditarium | KG + DL |
| 48 | severe dermatitis-multiple allergies-metabolic wasting syndrome | KG + DL |
| 49 | excessive tearing | KG + DL |
| 50 | thyroid gland disease | KG + DL |
(Showing top 50 of 93 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.